Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RLAY
#1753
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+14.77%
Monthly Change
+21.42%
6 month change
+185.79%
Cambio anual
+213.76%
Cierres anteriores
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
Volumen
219
Markets
Acciones
Atención Sanitaria
RLAY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
167.38 M
169.52 M
171.44 M
172.41 M
173.32 M
178.73 M
—
Valuation ratios
Enterprise value
1.03 B
574.14 M
355.64 M
482.6 M
813.18 M
1.43 B
3.08 B
Price to earnings ratio
-2.72
-1.75
-1.19
-1.8
-3.03
-5.25
-11.28
Price to sales ratio
92.58
58.82
57.74
70.14
105.82
—
—
Price to cash flow ratio
3.3
2.36
1.4
2.04
3.43
6.17
13.04
Price to book ratio
0.31
0.76
0.13
0.18
0.3
2.56
3.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.1
0.1
0.11
0.09
0.39
Return on equity %
0.11
0.1
0.11
0.11
0.12
0.1
0.43
Return on invested capital %
—
—
—
—
—
1 036.09
—
Gross margin %
—
—
100
100
—
100
—
Operating margin %
—
—
1 105.21
11.35 K
—
866.28
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
1 003.58
10.4 K
—
784.25
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
18.42
15.95
19.96
20.92
19.14
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0
0.01
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.54
0.41
0.43
0.32
0.36
0.26
1.38
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.09
0.87
0.55
0.67
0.53
0.49
2.24
Net current asset value per share
6.17
5.66
4.37
3.97
3.62
3.37
15.33
Tangible book value per share
5.97
5.43
4.25
3.89
3.53
3.3
14.96
Working capital per share
5.83
5.31
4.15
3.78
3.43
3.22
14.59
Book value per share
5.98
5.44
4.26
3.89
3.53
3.3
14.98
Noticias
Las acciones de Relay Therapeutics alcanzan un máximo de 52 semanas en 9,64 dólares
Relay Therapeutics stock hits 52-week high at 9.64 USD
Relay superaron 0.09$ las previsiones de BPA en el cuarto trimestre del año
Relay supera por 0,09$ las previsiones de BPA en el cuarto trimestre del año
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Resultados de Relay Therapeutics en foco tras avance de la FDA
Ganancias de Relay Therapeutics en foco tras avance con la FDA
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech: beneficio se dispara 660% en 2025, perspectiva cautelosa para 2026
BB Biotech: utilidad sube 660% en 2025, perspectiva cautelosa para 2026
Resultados de Relay en el centro de atención tras avance de la FDA